Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage - Akiyoshi Shimoda; Kazuhiro Murai; Hayato Hikita; Satoshi Minami; Takayuki Miyake; Shinji Kuriki; Emi Sometani; Jihyun Sung; Satoshi Shigeno; Yuichiro Higuchi; Kazuki Maesaka; Kumiko Shirai; et al. (PLoS ONE, 2026)